Tara Carlisle, MD

Assistant Professor, Neurology


FacultyPhoto
Medical School
  • MD, University of Colorado Denver School of Medicine (2007)
Graduate School
  • PhD, University of Colorado Health Sciences Center (2007)
Undergraduate School
  • BA/BS, University of Colorado - Boulder (CO) (2002)
Internship
  • University of Colorado (University Hospital) Program (2016)
Residency
  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School Program, Neurology (2017)
Fellowships
  • University of Colorado (University Hospital) Program, Neurology (2020)
Department
Neurology

Professional Titles

  • Assistant Professor

Research Interests

My research explores personalized risk assessment, lifestyle recommendations, and potential disease-altering approaches for those most likely to benefit. I have a passion for preventing dementia. I have an interest in cognitive decline in Parkinson's disease focusing on modifiable and/or treatable risk factors. I am interested in understanding the profound sex differences in Alzheimer's disease. I am also interested in the real-world response to anti-amyloid therapies in populations not well-represented in the original clinical trials including atypical presentations of Alzheimer's disease.

Publications

  • Carlisle TC, Galetta KM, McGinnis SM, Bockow Kaplan T. Clinical Reasoning: A 58-year-old woman presents with progressive memory deficits, odd behavior, and falls. Neurology. 2020 Feb 4;94(5):e557-e561. PubMed PMID: 31959711
  • Carlisle TC, Ribera AB. Connexin 35b expression in the spinal cord of Danio rerio embryos and larvae. J Comp Neurol. 2014 Mar;522(4):861-75. PubMed PMID: 23939687
  • Carlisle, T.C., Fought, A., Medina, L.D., Olson, K., Lopez-Esquibel, N., Simpson, A.E., and Holden, S.K. Longitudinal validity of UCSD performance-based skills assessment in Parkinson’s disease. Poster Presentation. American Academy of Neurology Annual Meeting, April 2021.
  • Holden, S.K., Fought, A., Olson, K., Lopez-Esquibel, N., Carlisle, T.C., and Medina, L.D. Initial longitudinal analyses of objectively assessed cognitive functional abilities in a cohort with Parkinson’s disease. Poster Presentation. Movement Disorders Society Congress, September 2021.
  • Carlisle TC, Olson KE, Carlson NE, Bettcher BM, Holden SK. Developing a Preliminary Parkinson’s Disease Risk Estimator for Decline In Cognition Tool (pPREDICT) as a Practical and Pragmatic Tool to Estimate Risk of Cognitive Decline (P1-1.Virtual). Neurology. 2022;98(18_supplement):3496. doi:doi:10.1212/WNL.98.18_supplement.3496
  • Carlisle TC, Olson KE, Carlson NE, Bettcher BM, Holden SK. Heterogeneous Longitudinal Cognitive Trajectories in Parkinson’s Disease, in Abstracts Presented at the 33rd Annual Meeting of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci. 2022;34(3):278–302. doi:10.1176/appi.neuropsych.20223401
  • Carlisle TC, Birlea M, Restrepo D, Filley CM. Headache-Associated Phantosmia as a Harbinger of Lewy Body Dementia. J Neuropsychiatry Clin Neurosci. Aug 22 2022:appineuropsych21110265. doi:10.1176/appi.neuropsych.21110265. PMID: 35989571.
  • Carlisle TC, Stanley MPH, Singhal AB, Caplan DN. Clinical Reasoning: An 81-Year-Old Woman Who Insisted the Hospital Was Her Home. Neurology. 2021 Oct 19;97(16):e1632-e1636. PubMed PMID: 34144999
  • Martin (Carlisle), T.C. and Ribera, A.B. (2013). Lessons from Zebrafish: Ion Channels Guide Neuronal Development. In Cellular Migration and Formation of Neuronal Connections: Comprehensive Developmental Neuroscience (Rakic, P., Rubenstein, J.L.R. eds.) Chapter 42: 791-809. San Diego: Elsevier.
  • Carlisle TC, Medina LD, Holden SK. Original research: initial development of a pragmatic tool to estimate cognitive decline risk focusing on potentially modifiable factors in Parkinson's disease. Front Neurosci. 2023;17:1278817. PubMed PMID: 37942138
  • Carlisle TC, Fought AJ, Olson KE, Lopez-Esquibel N, Simpson A, Medina LD, Holden SK. Original research: longitudinal evaluation of cognitively demanding daily function using performance-based functional assessment highlights heterogeneous trajectories in cognitive and functional abilities in people with Parkinson's disease. Front Neurosci. 2023;17:1200347. PubMed PMID: 37434765
  • Macchi ZA, Carlisle TC, Filley CM. Prognosis in substance abuse-related acute toxic leukoencephalopathy: A scoping review. J Neurol Sci. 2022 Nov 15;442:120420. PubMed PMID: 36156344
  • Bettcher, BM, Lopez Paniagua, D, Wang, Y, McConnell, BV, Coughlan, C, Carlisle, TC, Thaker, AA, Lippitt, W, Filley, CM, Pelak, VS, Shapiro, ALB, Heffernan, KS, Potter, H, Solano, DA, Boyd, J, Carlson, NE. Synergistic Effects of GFAP and Aß42: Implications for White Matter Integrity and Verbal Memory Across the Cognitive Spectrum. Brain, Behavior, & Immunity - Health. 2024; doi: 10.1016/j.bbih.2024.100834.
  • Carlisle TC. Frontotemporal Dementia. Reference Module in Neuroscience and Biobehavioral Psychology [Internet] Amsterdam, The Netherlands: Elsevier Inc.; 2024. Available from: https://doi.org/10.1016/B978-0-323-95702-1.00120-2 DOI: 10.1016/B978-0-323-95702-1.00120-2.
  • Roeske-Anderson L, Elliott G, Carlisle TC, Filley CM. Tree drawing analysis in the evaluation of traumatic brain injury: preliminary observations, in Abstracts Presented at the 33rd Annual Meeting of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci. 2022;34(3):278–302. doi:10.1176/appi.neuropsych.20223401
  • Carlisle TC, Petrucci SP, Callen A, Bettcher BM. A case of Alzheimer’s disease with contribution from frontal brain sagging syndrome with underlying Progranulin mutation – Hickam's dictum partially explained by Occam’s razor, in American Neuropsychiatric Association 2024 Annual Meeting Abstracts. J Neuropsychiatry Clin Neurosci. 2024;36(3): 229-277. https://doi.org/10.1176/appi.neuropsych.20243601
  • Bettcher BM, Lopez Paniagua D, Wang Y, McConnell BV, Coughlan C, Carlisle TC, Thaker A, Lippitt W, Filley CM, Pelak VS, Shapiro AL, Heffernan KS, Potter H, Solano A, Boyd J, Carlson NE. Synergistic Effects of GFAP and Aß42: Implications for White Matter Integrity and Verbal Memory Across the Cognitive Spectrum. Alzheimer's Dement. Alzheimer's Association International Conference; 2024 July.
  • Bettcher BM, Lopez Paniagua D, Wang Y, McConnell BV, Coughlan C, Carlisle TC, Thaker AA, Lippitt W, Filley CM, Pelak VS, Shapiro ALB, Heffernan KS, Potter H, Solano A, Boyd J, Carlson NE. Synergistic effects of GFAP and Aß42: Implications for white matter integrity and verbal memory across the cognitive spectrum. Brain Behav Immun Health. 2024 Oct;40:100834. PubMed PMID: 39206431
  • Carlisle TC. Frontotemporal Dementia. Reference Module in Neuroscience and Biobehavioral Psychology [Internet] Amsterdam, The Netherlands: Elsevier Inc.; 2024. Available from: https://doi.org/10.1016/B978-0-323-95702-1.00120-2 DOI: 10.1016/B978-0-323-95702-1.00120-2.
  • Carlisle TC, Petrucci SP, Callen A, Bettcher BM. A case of Alzheimer’s disease with contribution from frontal brain sagging syndrome with underlying Progranulin mutation – Hickam's dictum partially explained by Occam’s razor, in American Neuropsychiatric Association 2024 Annual Meeting Abstracts. J Neuropsychiatry Clin Neurosci. 2024;36(3): 229-277. https://doi.org/10.1176/appi.neuropsych.20243601
  • Bettcher BM, Lopez Paniagua D, Wang Y, McConnell BV, Coughlan C, Carlisle TC, Thaker A, Lippitt W, Filley CM, Pelak VS, Shapiro AL, Heffernan KS, Potter H, Solano A, Boyd J, Carlson NE. Synergistic Effects of GFAP and Aß42: Implications for White Matter Integrity and Verbal Memory Across the Cognitive Spectrum. Alzheimer's Dement. Alzheimer's Association International Conference; 2024 July.

Professional Memberships

  • Alpha Omega Alpha, Member
  • American Academy of Neurology, Member
  • American Neuropsychiatric Association, Member

Practice Locations

CU Memory Disorders Clinic - Central Park
3055 Roslyn Street
Suite 120
Denver, CO 80238
720-848-2080

Hospital Affiliation
  • University of Colorado Hospital

Specialty Information

Specialties
  • Neurology, Board Certification (2020)
  • Behavioral Neurology, Board Certification (2022)
Conditions & Treatments
  • Brain and Nervous System - Alzheimer's Disease
  • Brain and Nervous System
  • Brain and Nervous System - Cognitive Changes
  • Brain and Nervous System - Dementia with Lewy Bodies
  • Brain and Nervous System - Frontotemporal Dementia
  • Brain and Nervous System - Hydrocephalus
  • Brain and Nervous System - Lewy Body Dementia
  • Brain and Nervous System - Memory disorders
  • Brain and Nervous System - Memory Loss
  • Brain and Nervous System - Mild Cognitive Impairment
  • Brain and Nervous System - Parkinson's Disease Dementia
  • Brain and Nervous System - Posterior Cortical Atrophy
  • Brain and Nervous System - CADASIL Syndrome
  • Brain and Nervous System - Vascular Dementia
Care Philosophy
I strive to provide the best care for my patients. I believe in treating the person as a whole, taking every aspect of brain health into consideration during diagnosis and treatment.

Public Speaking
Yes
Neurodegenerative disorders, healthy aging, sex differences in cognition, anti-amyloid therapies